Lancashire and South Cumbria
Formulary
4 Central nervous system
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
04-07-03 Trigeminal neuralgia
Carbamazepine
Formulary
See section 4.8.1
Nortriptyline
Formulary
Links
LSCMMG: Primary Care Management of Neuropathic Pain
MHRA Drug Safety Update April 2022: Pregabalin (Lyrica): findings of safety study on risks during pregnancy
MHRA Drug Safety Update Feb 2021: Pregabalin (Lyrica): reports of severe respiratory depression
MHRA Drug Safety Update Oct 2017: Gabapentin (Neurontin): risk of severe respiratory depression
MHRA: Gabapentin (Neurontin): risk of severe respiratory depression
MHRA: Pregabalin (Lyrica): findings of safety study on risks during pregnancy
MHRA: Pregabalin (Lyrica): reports of severe respiratory depression
NICE CG173: Neuropathic pain in adults: pharmacological management in non-specialist settings
NICE CG59: Low back pain and sciatica in over 16s: assessment and management
NICE Unlicensed medicine review 27: Ketamine for chronic pain
Key
Full Site